Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic advances in the treatment of polycystic kidney disease.

Nephron. Clinical practice - 1 Jan 2014

Riella Cristian, Czarnecki Peter G, Steinman Theodore I

Abstract excerpt

The spectrum of polycystic kidney disease (PKD) comprises a family of inherited syndromes defined by renal cyst formation and growth, progressive renal function loss and variable extrarenal manifestations. The most common form, autosomal-dominant PKD is caused by mutations in one of two genes, PKD1 or PKD2. Recent developments in genomic and proteomic medicine have resulted in the discovery of novel genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cyclic AMP
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polycystic Kidney Diseases

Share to Proteomics

Share to Renin-Angiotensin System

Share to TOR Serine-Threonine Kinases

Share to TRPP Cation Channels

Source

Identifiers

PMID: 25573484
DOI: 10.1159/000368244

Genes

PKD1
PKD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic advances in the treatment of polycystic kidney disease.PMID 25573484Read ↗

Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.Semantic proximity Read ↗

[Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].Semantic proximity Read ↗

Therapeutic targets for polycystic kidney disease.Semantic proximity Read ↗

Autosomal Dominant Polycystic Kidney DiseaseSemantic proximity Read ↗

Recent advances in autosomal-dominant polycystic kidney disease.Semantic proximity Read ↗

Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.Semantic proximity Read ↗

The cellular pathways and potential therapeutics of Polycystic Kidney Disease.Semantic proximity Read ↗

[Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].Semantic proximity Read ↗

[Research advances in the diagnosis and treatment of Polycystic kidney disease].Semantic proximity Read ↗

Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.Semantic proximity Read ↗

Therapeutic Targets in Polycystic Liver DiseaseSemantic proximity Read ↗

Insights Into the Molecular Mechanisms of Polycystic Kidney DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.